Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Doximity
(NYSE:DOCS)
Intraday
$23.59
0
[0.00%]
After-Hours
$23.59
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$23.59
0
[0.00%]
At close: Apr 25
$23.59
0
[0.00%]
PreMarket: 4:00PM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Doximity Stock (NYSE:DOCS)
Doximity Stock (NYSE: DOCS)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, April 25, 2024
JP Morgan Upgrades Doximity to Neutral, Announces $25 Price Target
Benzinga Newsdesk
-
21 hours ago
Tuesday, April 23, 2024
6 Analysts Assess Doximity: What You Need To Know
Benzinga Insights
-
2 days ago
Morgan Stanley Maintains Underweight on Doximity, Maintains $25 Price Target
Benzinga Newsdesk
-
2 days ago
Tuesday, April 02, 2024
6 Analysts Assess Doximity: What You Need To Know
Benzinga Insights
-
Apr 2, 2024, 8:00AM
Evercore ISI Group Maintains In-Line on Doximity, Maintains $30 Price Target
Benzinga Newsdesk
-
Apr 2, 2024, 7:03AM
Monday, April 01, 2024
Watching Doximity; Shares Move Lower As Traders Ciruclate Jehoshaphat Research Post On X "OUR NEW SHORT: DOXIMITY $DOCS"
Benzinga Newsdesk
-
Apr 1, 2024, 9:51AM
Friday, March 15, 2024
What 6 Analyst Ratings Have To Say About Doximity
Benzinga Insights
-
Mar 15, 2024, 11:01AM
JP Morgan Maintains Underweight on Doximity, Raises Price Target to $25
Benzinga Newsdesk
-
Mar 15, 2024, 10:08AM
Monday, February 26, 2024
Forecasting The Future: 5 Analyst Projections For Doximity
Benzinga Insights
-
Feb 26, 2024, 9:00AM
Leerink Partners Initiates Coverage On Doximity with Market Perform Rating, Announces Price Target of $32
Benzinga Newsdesk
-
Feb 26, 2024, 8:38AM
Friday, February 09, 2024
Truist Securities Maintains Hold on Doximity, Raises Price Target to $29-Report released on 8th February 2024
Benzinga Newsdesk
-
Feb 9, 2024, 4:46PM
What's Going With Medical Professionals-Networking Service Doximity Stock Today?
Vandana Singh
-
Feb 9, 2024, 12:00PM
Wells Fargo Maintains Equal-Weight on Doximity, Raises Price Target to $27
Benzinga Newsdesk
-
Feb 9, 2024, 9:26AM
Doximity shares are trading lower after the company issued Q4 revenue guidance below estimates.
Benzinga Newsdesk
-
Feb 9, 2024, 8:44AM
Thursday, February 08, 2024
Doximity shares are trading lower after the company issued Q4 revenue guidance below estimates.
Benzinga Newsdesk
-
Feb 8, 2024, 4:46PM
Doximity Sees FY 2024 Revenue $473.3M-$474.3M Vs $467.320M Est.
Benzinga Newsdesk
-
Feb 8, 2024, 4:38PM
Doximity Sees Q4 2024 Revenue $115.9M-$116.9M Vs $117.884M Est.
Benzinga Newsdesk
-
Feb 8, 2024, 4:38PM
Recap: Doximity Q3 Earnings
Benzinga Insights
-
Feb 8, 2024, 4:05PM
Doximity Q3 2024 Adj EPS $0.29 Beats $0.23 Estimate, Sales $135.28M Beat $127.49M Estimate
Benzinga Newsdesk
-
Feb 8, 2024, 4:03PM
Earnings Scheduled For February 8, 2024
Benzinga Insights
-
Feb 8, 2024, 4:43AM
Tuesday, January 23, 2024
B of A Securities Maintains Neutral on Doximity, Raises Price Target to $32
Benzinga Newsdesk
-
Jan 23, 2024, 4:19PM
Tuesday, January 02, 2024
B of A Securities Upgrades Doximity to Neutral, Raises Price Target to $29
Benzinga Newsdesk
-
Jan 2, 2024, 7:48AM
Monday, December 25, 2023
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
-
Dec 25, 2023, 12:35PM
Friday, November 17, 2023
Top 5 Health Care Stocks That May Collapse In November
Lisa Levin
-
Nov 17, 2023, 8:33AM
Friday, November 10, 2023
Piper Sandler Maintains Neutral on Doximity, Raises Price Target to $23
Benzinga Newsdesk
-
Nov 10, 2023, 5:24PM
Why Wynn Resorts Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Lisa Levin
-
Nov 10, 2023, 1:34PM
Doximity Options Trading: A Deep Dive into Market Sentiment
Benzinga Insights
-
Nov 10, 2023, 1:18PM
Big Stocks Moving Higher On Friday: Synaptics Reports Q1 Beat; Joins Lyft, Hologic, Blink Charging
Lisa Levin
-
Nov 10, 2023, 11:51AM
Morgan Stanley Maintains Underweight on Doximity, Raises Price Target to $25
Benzinga Newsdesk
-
Nov 10, 2023, 9:00AM
Doximity shares are trading higher after the company reported better-than-expected Q2 financial results and issued Q3 and FY24 revenue guidance above estimates.
Benzinga Newsdesk
-
Nov 10, 2023, 8:33AM
Thursday, November 09, 2023
Doximity shares are trading higher after the company reported better-than-expected Q2 financial results and issued Q3 and FY24 revenue guidance above estimates.
Benzinga Newsdesk
-
Nov 9, 2023, 5:03PM
Doximity Sees FY24 Revenue $460M-$472M Vs $458.74M Est.
Benzinga Newsdesk
-
Nov 9, 2023, 4:56PM
Doximity Sees Q3 Revenue $127M-$128M Vs $122.47M Est.
Benzinga Newsdesk
-
Nov 9, 2023, 4:56PM
Doximity Q2 Adj EPS $0.22 Beats $0.18 Estimate, Sales $113.61M Beat $109.06M Estimate
Benzinga Newsdesk
-
Nov 9, 2023, 4:53PM
Online Networking Service Doximity Stock Soars On Q2 Performance - Here's Why
Adam Eckert
-
Nov 9, 2023, 4:51PM
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
-
Nov 9, 2023, 4:31PM
Doximity: Q2 Earnings Insights
Benzinga Insights
-
Nov 9, 2023, 4:05PM
Earnings Scheduled For November 9, 2023
Benzinga Insights
-
Nov 9, 2023, 6:52AM
Monday, October 23, 2023
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
-
Oct 23, 2023, 1:35PM
Tuesday, September 19, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Sep 19, 2023, 12:50PM
Friday, September 15, 2023
Doximity Chief Financial Officer Acquires 35,000 Shares After Exercising Company Stock Options
Benzinga Insights
-
Sep 15, 2023, 11:01AM
Tuesday, September 05, 2023
Where Doximity Stands With Analysts
Benzinga Insights
-
Sep 5, 2023, 3:00PM
Canaccord Genuity Maintains Buy on Doximity, Lowers Price Target to $33
Benzinga Newsdesk
-
Sep 5, 2023, 12:29PM
Monday, August 14, 2023
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
-
Aug 14, 2023, 1:35PM
Friday, August 11, 2023
Wells Fargo Maintains Equal-Weight on Doximity, Lowers Price Target to $25
Benzinga Newsdesk
-
Aug 11, 2023, 7:05AM
Wednesday, August 09, 2023
Why Cutera Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Wednesday's Session
Lisa Levin
-
Aug 9, 2023, 3:17PM
Why Doximity Stock Took A Nosedive Today
Ryan Gustafson
-
Aug 9, 2023, 2:37PM
Benzinga's Top Ratings Upgrades, Downgrades For August 9, 2023
Benzinga Insights
-
Aug 9, 2023, 11:00AM
Truist Securities Maintains Hold on Doximity, Lowers Price Target to $28
Benzinga Newsdesk
-
Aug 9, 2023, 10:00AM
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
-
Aug 9, 2023, 9:06AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch